A non-randomized pilot study to test the feasibility of treating chronic pain and opioid prescription use in rural areas with acceptance and commitment therapy (T-PACT)
© The Association for Clinical and Translational Science 2020..
Chronic non-cancer pain (CNCP) involves one-third of the US population, and prescription opioids contribute to the opioid epidemic. The Centers for Disease Control and Prevention emphasizes maximizing non-opioid treatment, but many rural populations cannot access alternative therapies. Clinical and Translational Science Award hubs across four rural states performed a multi-site, single-arm intervention feasibility study testing methods and procedures of implementing a behavioral intervention, acceptance and commitment therapy, in primary care CNCP patients on chronic opioids. Using the CONSORT extension for feasibility studies, we describe lessons learned in recruiting/retaining participants, intervention implementation, data measurement, and multi-site procedures. Results inform a future definitive trial and potentially others conducting rural trials.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:4 |
|---|---|
| Enthalten in: |
Journal of clinical and translational science - 4(2020), 5 vom: 24. März, Seite 472-476 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rhyne, Robert L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acceptance and commitment therapy |
|---|
| Anmerkungen: |
Date Revised 06.04.2021 published: Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1017/cts.2020.26 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM318109360 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM318109360 | ||
| 003 | DE-627 | ||
| 005 | 20231225164651.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1017/cts.2020.26 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1060.xml |
| 035 | |a (DE-627)NLM318109360 | ||
| 035 | |a (NLM)33244439 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Rhyne, Robert L |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A non-randomized pilot study to test the feasibility of treating chronic pain and opioid prescription use in rural areas with acceptance and commitment therapy (T-PACT) |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 06.04.2021 | ||
| 500 | |a published: Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Association for Clinical and Translational Science 2020. | ||
| 520 | |a Chronic non-cancer pain (CNCP) involves one-third of the US population, and prescription opioids contribute to the opioid epidemic. The Centers for Disease Control and Prevention emphasizes maximizing non-opioid treatment, but many rural populations cannot access alternative therapies. Clinical and Translational Science Award hubs across four rural states performed a multi-site, single-arm intervention feasibility study testing methods and procedures of implementing a behavioral intervention, acceptance and commitment therapy, in primary care CNCP patients on chronic opioids. Using the CONSORT extension for feasibility studies, we describe lessons learned in recruiting/retaining participants, intervention implementation, data measurement, and multi-site procedures. Results inform a future definitive trial and potentially others conducting rural trials | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Feasibility study | |
| 650 | 4 | |a acceptance and commitment therapy | |
| 650 | 4 | |a chronic non-cancer pain | |
| 650 | 4 | |a opioid | |
| 650 | 4 | |a pilot study | |
| 700 | 1 | |a Rishel Brakey, Heidi |e verfasserin |4 aut | |
| 700 | 1 | |a Halladay, Jacquie R |e verfasserin |4 aut | |
| 700 | 1 | |a Mottus, Kathleen |e verfasserin |4 aut | |
| 700 | 1 | |a Greiner, K Allen |e verfasserin |4 aut | |
| 700 | 1 | |a Salt, Elizabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Myers, Orrin |e verfasserin |4 aut | |
| 700 | 1 | |a Sutton, Kent |e verfasserin |4 aut | |
| 700 | 1 | |a Fuentes, Jesus |e verfasserin |4 aut | |
| 700 | 1 | |a Vowles, Kevin E |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical and translational science |d 2017 |g 4(2020), 5 vom: 24. März, Seite 472-476 |w (DE-627)NLM271221658 |x 2059-8661 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:2020 |g number:5 |g day:24 |g month:03 |g pages:472-476 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1017/cts.2020.26 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 2020 |e 5 |b 24 |c 03 |h 472-476 | ||